prof. MUDr. Marek Svoboda, Ph.D.
Professor, Comprehensive Cancer Care Department
office: pav. Švejdův
Žlutý kopec 534/7
656 53 Brno
phone: | +420 543 134 102, +420 543 134 103 |
---|---|
e‑mail: |
social and academic networks: |
---|
Total number of publications: 340
2016
-
MiR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagus
Tumor Biology, year: 2016, volume: 37, edition: 6, DOI
-
MiR-338-5p sensitizes glioblastoma cells to radiation through regulation of genes involved in DNA damage response
Tumor Biology, year: 2016, volume: 37, edition: 6, DOI
-
MiR-429 is linked to metastasis and poor prognosis in renal cell carcinoma by affecting epithelial-mesenchymal transition
Tumor Biology, year: 2016, volume: 37, edition: 11, DOI
-
Mutational analysis of primary and metastatic colorectal cancer samples underlying the resistance to cetuximab-based therapy
ONCOTARGETS AND THERAPY, year: 2016, volume: 9, edition: July, DOI
-
Outcomes for Patients with Metastatic Renal Cell Carcinoma Achieving a Complete Response on Targeted Therapy: A Registry-based Analysis.
European Urology, year: 2016, volume: 70, edition: 3, DOI
-
Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer
Tumor Biology, year: 2016, volume: 37, edition: 10, DOI
-
Přestavby chromosomů u onkologických pacientů a u pracovníků v riziku expozice cytostatiky a ionizujícím zářením.
Year: 2016, type: Conference abstract
-
Serum-Based MicroRNA Signatures in Early Diagnosis and Prognosis Prediction of Colon Cancer
Carcinogenesis, year: 2016, volume: 37, edition: 10, DOI
-
Současné možnosti predikce odpovědi na cílenou anti-EGFR léčbu metastatického kolorektálního karcinomu
Klinická onkologie, year: 2016, volume: 29, edition: 3, DOI
-
Terapie pacientek s triple negativním karcinomem prsu
20. Mamologické symposium, year: 2016